Open access
143
Views
0
CrossRef citations to date
0
Altmetric
Review
Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib
Erika Rijavec1 Medical Oncology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-8547-3346
Federica Biello2 Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy
, Alice Indini3 Division of Medical Oncology, University of Insubria, ASST dei Sette Laghi, Varese, Italy
, Francesco Grossi3 Division of Medical Oncology, University of Insubria, ASST dei Sette Laghi, Varese, Italy
& Carlo Genova4 UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy;5 Department of Internal Medicine and Medical Specialties (DIMI), Università degli Studi di Genova, Genova, Italy
https://orcid.org/0000-0003-3690-8582
Pages 1-9
|
Published online: 20 Jan 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.